𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study

✍ Scribed by Weinblatt, M. E.; Fleischmann, R.; Huizinga, T. W. J.; Emery, P.; Pope, J.; Massarotti, E. M.; van Vollenhoven, R. F.; Wollenhaupt, J.; Bingham, C. O.; Duncan, B.; Goel, N.; Davies, O. R.; Dougados, M.

Book ID
118017331
Publisher
Oxford University Press
Year
2012
Tongue
English
Weight
260 KB
Volume
51
Category
Article
ISSN
1462-0324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

American College of Rheumatology hybrid
American College of Rheumatology hybrid analysis of certolizumab pegol plus methotrexate in patients with active rheumatoid arthritis: Data from a 52-week phase III trial
✍ R. F. van Vollenhoven; D. Felson; V. Strand; M. E. Weinblatt; K. Luijtens; E. C. πŸ“‚ Article πŸ“… 2010 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 101 KB πŸ‘ 2 views

## Abstract ## Objective The American College of Rheumatology (ACR) hybrid (a modified mean percent response to treatment) was officially recommended by the ACR as a revision to 20%, 50%, and 70% response criteria (ACR20/50/70) scores, but has not been tested in clinical trials. We performed a pos

The efficacy and safety of leflunomide i
The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five-year followup study
✍ J. R. Kalden; M. Schattenkirchner; H. SΓΆrensen; P. Emery; C. Deighton; B. Rozman πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 2 views

## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, open‐label extension of 2 phase III double‐blind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t